BeOne Medicines AG Statistics
Total Valuation
SHA:688235 has a market cap or net worth of CNY 252.62 billion. The enterprise value is 231.29 billion.
| Market Cap | 252.62B |
| Enterprise Value | 231.29B |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 115.06M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +6.60% |
| Shares Change (QoQ) | +1.74% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 67.92M |
Valuation Ratios
The trailing PE ratio is 517.64 and the forward PE ratio is 72.40.
| PE Ratio | 517.64 |
| Forward PE | 72.40 |
| PS Ratio | 7.14 |
| PB Ratio | 8.59 |
| P/TBV Ratio | 8.73 |
| P/FCF Ratio | 65.16 |
| P/OCF Ratio | 45.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 95.13, with an EV/FCF ratio of 59.66.
| EV / Earnings | 473.93 |
| EV / Sales | 6.58 |
| EV / EBITDA | 95.13 |
| EV / EBIT | 200.03 |
| EV / FCF | 59.66 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.25.
| Current Ratio | 2.39 |
| Quick Ratio | 2.09 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 2.82 |
| Debt / FCF | 1.87 |
| Interest Coverage | 6.93 |
Financial Efficiency
Return on equity (ROE) is 1.81% and return on invested capital (ROIC) is 2.36%.
| Return on Equity (ROE) | 1.81% |
| Return on Assets (ROA) | 1.69% |
| Return on Invested Capital (ROIC) | 2.36% |
| Return on Capital Employed (ROCE) | 3.45% |
| Revenue Per Employee | 3.22M |
| Profits Per Employee | 44,366 |
| Employee Count | 11,000 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.43 |
Taxes
In the past 12 months, SHA:688235 has paid 809.54 million in taxes.
| Income Tax | 809.54M |
| Effective Tax Rate | 62.39% |
Stock Price Statistics
The stock price has increased by +61.81% in the last 52 weeks. The beta is 0.46, so SHA:688235's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +61.81% |
| 50-Day Moving Average | 287.70 |
| 200-Day Moving Average | 254.28 |
| Relative Strength Index (RSI) | 45.80 |
| Average Volume (20 Days) | 2,961,734 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.78 |
Income Statement
In the last 12 months, SHA:688235 had revenue of CNY 35.40 billion and earned 488.02 million in profits. Earnings per share was 4.16.
| Revenue | 35.40B |
| Gross Profit | 30.51B |
| Operating Income | 1.29B |
| Pretax Income | 1.30B |
| Net Income | 488.02M |
| EBITDA | 2.34B |
| EBIT | 1.29B |
| Earnings Per Share (EPS) | 4.16 |
Balance Sheet
The company has 28.74 billion in cash and 7.26 billion in debt, giving a net cash position of 21.48 billion.
| Cash & Cash Equivalents | 28.74B |
| Total Debt | 7.26B |
| Net Cash | 21.48B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 29.40B |
| Book Value Per Share | 265.75 |
| Working Capital | 23.47B |
Cash Flow
In the last 12 months, operating cash flow was 5.59 billion and capital expenditures -1.71 billion, giving a free cash flow of 3.88 billion.
| Operating Cash Flow | 5.59B |
| Capital Expenditures | -1.71B |
| Free Cash Flow | 3.88B |
| FCF Per Share | n/a |
Margins
Gross margin is 86.19%, with operating and profit margins of 3.66% and 1.38%.
| Gross Margin | 86.19% |
| Operating Margin | 3.66% |
| Pretax Margin | 3.67% |
| Profit Margin | 1.38% |
| EBITDA Margin | 6.60% |
| EBIT Margin | 3.66% |
| FCF Margin | 10.95% |
Dividends & Yields
SHA:688235 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.60% |
| Shareholder Yield | -6.60% |
| Earnings Yield | 0.19% |
| FCF Yield | 1.53% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:688235 has an Altman Z-Score of 4.29 and a Piotroski F-Score of 8.
| Altman Z-Score | 4.29 |
| Piotroski F-Score | 8 |